an integrated evaluation strategy for making regulatory ...vision by the u. s. national academy of...
TRANSCRIPT
1
An Integrated Evaluation Strategy for Making Regulatory Decisions:
Moving From Data Requirements to Knowledge Requirements.
Douglas C. Wolf, D.V.M., Ph.D., Fellow IATP, ATSOffice of Research and Development
U. S. [email protected]
2
Overview of Presentation
Proposals that Stimulated the Change
Issues that have to be Addressed
Examples of Legislative Context
Problem Formulation for Regulatory Decisions
Approaches to Establish Necessary Knowledge and Supporting Activities
What the Future Will Look Like and How to Make It Happen
3
The Future of Toxicology…the application of mathematical and computer models and molecular biological approaches to improve…prioritization of data requirements and risk assessments.
To support the evolution of toxicology from a predominantly observational science at the level of disease-specific models to a predominantly predictive science focused upon a broad inclusion of target specific, mechanism-based, biological observations.
…a new toxicity-testing system that evaluates biologically significant perturbations in key toxicity pathways by using new methods in computational biology and a comprehensive array of in vitro tests based on human biology.
2003 2004 2007http://ntp.niehs.nih.govwww.epa.gov/ncct
http://dels.nas.edu/Report/Toxicity-Testing-Twenty-first/11970
4
NAS Vision for the Future
“Work towards transition to new integrative and predictive molecular and computational techniques to enhance efficiency and accuracy and to reduce reliance on animal testing.”
Vision by the U. S. National Academy of Sciences National Research Council 2007 report, Toxicity Testing in 21st Century: A Vision and a Strategy
“The difficulty lies, not in the new ideas, but in escaping from the old ones”John Maynard Keynes (1883–1946), British economist
5
Toxicity Testing in 21st Century: A Vision and a Strategy
6
Goal
Integrated evaluation strategy that provides the necessary scientific knowledge to make a regulatory determination of the potential for an adverse impact, from the use of a chemical, on public health and the environment with speed, efficiency and accuracy.
7
Problem StatementWhat is needed is a conceptual breakthrough which would
enable tailored risk assessments for a variety of risk management contexts; using in vitro, in silico and other new technology based on an integrated evaluation strategy.
Allowing significantly more chemicals to be assessed without increasing the amount of resources needed for testing or evaluation;
Allowing new methods to be incorporated as they develop;
Improve relevance and accuracy while reducing the reliance on whole animal testing;
Taking exposure and modes of action into consideration.
8
Why do we order a buffet when we need a simple balanced meal?
9
10
I’LL HAVE A RAT AND MOUSE 2 YEAR STUDY, A MULTIGEN..... OH AND AN IN VITRO ASSAY, I’VE GOT TO WATCH MY ANIMAL USAGE!
11
We need something like this.
12
Toxic Substances Control Act of 1976adequate data should be developedinformation relating to chemical characteristicstest data to determine an unreasonable riskperiodic review of the standards for data developmentmethods for prioritization of data needsSAR methodspredictive modelsestablish screening methods and the scientific basis for these methods
Safe Chemicals Act of 2010develop minimum data setinformation on chemical characteristicsinformation on use and exposuredevelop alternative (non animal based) test methodsdevelop a strategic plan for implementing alternative test methodsuse test methods that eliminate or reduce animal useencourage submission of data using new methodssupport the scientific basis for new method development
13
Safe Drinking Water Act (SDWA)as amended 1996SEC. 1442. (A) improved methods(i) to identify and measure the existence of contaminants in drinking water,(ii) to identify the source of such contaminants;(B) improved methods to identify and measure the health effects of contaminants in drinking water;
Clean Water Act (CWA)as amended 1987SEC. 104. (1) …conduct and promote the coordination and acceleration of, research, investigations, experiments, training, demonstrations, surveys, and studies relating to the causes, effects, extent, prevention, reduction, and elimination of pollution;
14
Source-Exposure-Dose-Effects Continuum
TRANSPORT / TRANSFORMATION
ALTERED STRUCTURE / FUNCTION
ENVIRONMENTAL CHARACTERIZATION
SOURCE / STRESSOR FORMATION
DOSE
EXPOSURE
EARLY KEY BIOLOGICAL EVENTS
DISEASE
Toxicity Pathway
ChemicalPhysicalMicrobial
MagnitudeDurationTiming
DispersionKineticsThemodynamicsDistributionsMeteorology
AirWaterDietSoil & dust
PathwayRouteDurationFrequencyMagnitude
Statistical ProfileReference PopulationSusceptible Individual
Susceptible SubpopulationsPopulation Distributions
AbsorbedTargetInternal
Biologically Effective
MolecularBiochemicalCellularOrganOrganism
EdemaArrhythmiaNecrosisetc.
CancerAsthmaInfertilityetc.
Community
ActivityPatterns
PBPKModels
Transport,Transformation &
Fate Models
ExposureModels
BBDRModels
15
Chemical
RELEASE FATE / TRANSPORT CONCENTRATION ACTIVITY EXPOSURE
Intermediates
Degradates
PR
OD
UC
T n
PR
OD
UC
T …
PR
OD
UC
T 8
PR
OD
UC
T 7P
RO
DU
CT 6
PR
OD
UC
T 5P
RO
DU
CT 4
PR
OD
UC
T 3P
RO
DU
CT 2
PRO
DU
CT 1
Release
Reaction
ProductUse
Disposal
LocationFrequencyTiming
PopulationMarket Share
Water
OutdoorAir
SurfaceDust
A C
T I V
I T I E
S
Soil
IndoorAir
Food
ChemicalManufacture
ChemicalTransportation
Production/Formulation
WorkplaceExposure
EnvironmentalRelease
EnvironmentalDisposal
Air
Water
Incineration
Recycling SewageTreatment
Food
A C
T I V
I T I E
S
Land
Transport
EnvironmentalExposure
EnvironmentalRelease
Food
Water
Land
ProductDisposal
Air
A C
T I V
I T I E
S
EnvironmentalExposure
EnvironmentalExposure
Lifecycle Analysis
Consistant with NAS Science and Decisions and TSCA 2010
16
National Academy of ScienceExposure Project
Human and Environmental Exposure Science in the 21st Century
Develop a long-range vision for exposure science and a strategy with goals and objectives for implementing the vision over the next twenty years.
It will include development of a unifying conceptual framework for advancement of exposure science to study and assess human and ecological contact with chemical, biological, and physical stressors in their environments.
http://dels.nas.edu/Study-In-Progress/Human-Environmental-Exposure-Science/DELS-BEST-09-02
17
Threshold of Toxicological ConcernRisk assessment tool based on the establishment of a human exposure threshold value for chemicals, below which there is a very low probability of adverse effects to human health.
A safe level of exposure can be identified for many chemicals based on their chemical structure and the known toxicity of chemicals which share similar structural characteristics.
Information on human exposure is crucial.
Use of the Threshold of Toxicological Concern (TTC) Approach forthe Safety Assessment of Chemical SubstancesSCCP/1171/08, 19.11.08 European Commission 2008
18
Class I:Simple chemical structure and efficient metabolism that would suggest a low order of oral toxicity.
Class II:Less knowledge of metabolism and toxicology, but there is no clear indication of toxicity. Most substances in this class have functional groups similar to Class I but somewhat more reactive; more complex structures than substances in Class I
Class III:Chemical structure that permit no strong initial presumption of safety.May suggest significant toxicity.
Structural information based on a "decision tree" algorithm and grouped into three structural classes reflecting a presumed low, moderate and significant toxicity.
Cramer GM, Ford RA, Hall RA (1978). Estimation of toxic hazard – a decision tree approach. Food Cosmet Toxicol, 16: 255-276.
19
International Life Sciences Instituteilsi.org
ILSI North AmericaRefining TTC as tool for prioritization of food contaminants
ILSI Research FoundationExtending TTC to support risk assessment of biocides
ILSI Health and Environmental Sciences InstituteTTC as a tool in mixtures risk assessment
ILSI EuropeTTC Task Force
20
Classification based on inherent properties
For a chemical: Inherency relates to those chemical-specific properties associated with its impact on humans and the environment. (EPA perspective)
The physico-chemical and material properties, atomic composition, structure, size, surface area, solubility, surface charge, aspect ratio, etc.
The ability to interact with biological processes.
How it is made, used, degraded and disposed of.
21
Initial Screening will Require Relational Integrated and Interactive Knowledgebases
Development and expansion of knowledgebases that describe inherent properties of chemicals based on their known molecular structure, and chemical and biological interactions.
Ashby's poly-carcinogen
Represents a hypothetical chemical made of many of the known structural alerts for mutagenicity.
Benigni et al, J Environ Sci Health C 25:53-97Modified fromAshby, J. (1985) Environ.Mutagen 7 , pp. 919-921.
22
23
Metabolism and Degradate Pathway Analysis
Systematic compilation of information on observed metabolites, biotransformation reaction types, and relative biotransformationrates into a structure-searchable database.
Structure-based identification of metabolites and transformations
Identification of differences in metabolism based on gender, exposure dose, species, and methods
Identification of similar metabolites arising from different parent chemicals.
Identification of metabolites as residues in the food web.
Develop a metabolism simulator.
24
Clustering Using Inherent Properties
Chemistry-based Characteristics
356
21
27
100
350 429
6
Biological Responses
Use and Exposure Considerations
25
Design for the Environment
Clustering by inherent properties will enable identification of negative chemical features such as toxicity, persistence, and bioaccumulation.
Clustering by inherent properties will ALSO enable identification of positive chemical features such as minimal toxicity, no persistence, and lack of bioaccumulation.
26
Tiered Testing
Most tiered testing discussions have been focused on developing approaches that are geared toward limiting or eliminating whole animal testing.
Specifically decreasing or eliminating use of mammalian experiments using primates, canines, rodents, and related species.
27
Research: Learn & Refine
Screening and
Prioritizationand
Evaluation of knowledge sufficiency
Evaluation for Relevant Effects
Risk C
haracterization, Evaluation, and D
ecision
C2Cl3
ClClC
C2Cl3
ClClC
Cl
ClClCl
Cl
Cl
ClClCl
Cl
Cl
Cl
Cl
OHOH OH
Cl
Cl
OH
Cl
ClClCl
Cl
Cl
ClClCl
Cl
Cl
C2Cl3
ClClC
C2Cl3
ClClC
Cl
ClClCl
Cl
Cl
ClClCl
Cl
Cl
Cl
Cl
OHOH OH
Cl
Cl
OH
Cl
ClClCl
Cl
Cl
ClClCl
Cl
ClChemical Inventories
C2Cl3
Cl C
lC
C2Cl3
Cl C
lC
C2Cl3
Cl C
lC
C2Cl3
Cl C
lC
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl C
l
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl C
l
Cl
Cl
Cl
OH
OH
OH
Cl
Cl
OH
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl C
l
Cl
OH
C2Cl3
Cl C
lC
Cl
Cl
OH
OH
Cl C
l
OH
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl C
l
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl C
l
Cl
Cl
Cl
OH
OH
Cl
Cl
OH
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl C
l
Cl
OH
Cl
Cl
OH
OH
OH
Cl C
l
OH
Cl
Cl
OH
OH
Cl
Cl
OH
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl C
l
Cl O
H
Cl
Cl
OH
In Vitro Profiling: Molecular
interactions, Cellular Responses
QBAR
Existing Knowledge, exposure, use,
toxicity data, SAR, metabolism
prediction, degradateanalysis, QSAR
Efficient Focused In
Vivo Testing
28
EPA has a lot of experience with Hazard prediction and Chemical databases – a few examples
Analog Identification Methodology (AIM)identifies close structural analogs that have measured data and points to sources where those data can be found
Ecological Structure Activity Relationships (ECOSAR) estimates the aquatic toxicity of industrial chemicals
ECOTOX chemical toxicity data for aquatic life, terrestrial plants and wildlife
EPI Suite™estimates physical / chemical properties and environmental fate
High Production Volume Information System (HPVIS) health and environmental effects information
OncoLogicTM
evaluates the likelihood that a chemical may cause cancer
Use Cluster Scoring System (UCSS)risk-screening system into which chemicals are grouped by common use
29
Moving beyond data warehouses to integrated knowledgebases
A knowledge-based system uses artificial intelligence techniques in problem-solving processes to support human decision-making, learning, and action.
ACToR: Aggregated Computational Toxicology ResourceAggregates data from over 500 public sources on over 500,000 environmental chemicals searchable by chemical name, structure, and other identifiers. Data includes chemical structure, physico-chemical values, in vitro assay data and in vivo toxicology data.
Distributed Structure-Searchable Toxicity (DSSTox) Database NetworkStructure-activity and predictive toxicology using structure searchable standardized chemical structure files associated with toxicity data.
ToxRefDB: Toxicity Reference DatabaseDetailed chemical toxicity data in an accessible and searchable format. Links to other public hazard, exposure and risk resources.
30
Taking advantage of the development of knowledgebases and moving beyond just focusing on decreasing animal use.
An evaluation strategy that results in confidence that regulatory decisions are adequately protective of public health and the environment.
Increasing levels of certainty based on the risk context of the regulatory decision.
31
Increa
sing
certa
inty
Exposure, Dose and Route, Mode of Action/Relevance, in vitro assays, in vivo assays, in silico evaluation, level of acceptance, integration of informationExposure, Dose and Route,
Mode of Action/Relevance, in vitro assays, in vivo assays, in silicoevaluation, level of acceptance, integration of information
Exposure, Dose and Route, Mode of Action/Relevance, in vitro assays, in vivo assays, in silico evaluation, level of acceptance, integration of information
An Integrated Evaluation Strategy
Toxicity Testing in 21st Century: A Vision and a Strategy
32Modified from NRC, 2007
Source
Fate/Transport
Exposure
Tissue Dose
Biologic Interaction
Perturbation
BiologicInputs
NormalBiologicFunction
Morbidityand
Mortality
Cell Injury
Adaptive StressResponses
Early CellularChanges
• Quantitative Dose-Response• PK / PD• Toxicity Pathway Identification• in silico models •Targeted Testing
Toxicity Pathways: Cellular response pathways that, when sufficiently perturbed, are expected to result in adverse health effects.
33
Toxicity Pathway
Cellular response pathways that, when sufficiently perturbed, are expected to result in adverse health effects are termed toxicity pathways.
NRC (2007). Toxicity Testing in the Twenty-first Century: A Vision and a Strategy. Washington, DC, National Academy of Sciences. 216 p.
Source
EnvironmentalContaminant
Exposure
Molecular Initiating Event Cellular Effects Individual Population Community
Application to Levels of Organization Based on
Source to Outcome
Toxicity Pathway
Mode of Action
Adverse Outcome Pathway
Source to Outcome Pathway34
35
Molecular Initiating EventThe initial point of chemical-biological interaction within the organism that starts the pathway is a molecular initiating event.
Mode of ActionKey events and processes, starting with the interaction of an agent with the target cell, through functional and anatomical changes, resulting in cancer or other adverse health effects. Biological responses along the pathway that lead to, and are experimentally or toxicologically associated with, the adverse outcome are referred to as “key events”. All of these are empirically observable precursor steps that are a necessary element of the mode-of-action or are a biological marker for such an element.
USEPA (2005). Guidelines for Carcinogen Risk Assessment (Final). R. A. Forum, U.S. Environmental Protection Agency. EPA/630/P-03/001F. p 166. Boobis, A.R., et al. (2008). "IPCS framework for analyzing the relevance of a noncancer mode of action for humans." Crit Rev Toxicol 38(2): 87-96.
36
Adverse Outcome PathwayAn adverse outcome pathway (AOP) represents existing knowledge concerning the linkage between a direct molecular initiating event and an adverse outcome relevant to risk assessment at the individual or population levels thus spanning multiple levels ofbiological organization.
Ankley, G.T., et al. (2010). "Adverse Outcome Pathways: A Conceptual Framework to Support Ecotoxicology Research and Risk Assessment." Environmental Toxicology and Chemistry 29(3): 730-741.
Source to OutcomeThe continuum or cascade of measurable events starting from release into the environment and ending at an adverse outcome.
USEPA (2003). A Framework for a Computational Toxicology Research Program. PA/600/R-03/065. p 5.
Application to Levels of Organization Based on Source
to Outcome Source
EnvironmentalContaminant
Cellular Effects
Individual
Population
Community
Exposure
Molecular Initiating Event
Mode of Action
Adverse Outcome Pathway
Source to Outcome Pathway
Toxicity Pathway
37
38
Toxicity Testing in 21st Century: A Vision and a Strategy
Modified from NRC, 2007
Source
Fate/Transport
Exposure
Tissue Dose
Biologic Interaction
Perturbation
BiologicInputs
NormalBiologicFunction
Morbidityand
Mortality
Cell Injury
Adaptive StressResponses
Early CellularChanges
• Quantitative Dose-Response• PK / PD• Toxicity Pathway Identification• in silico models •Targeted Testing
Toxicity Pathways: Cellular response pathways that, when sufficiently perturbed, are expected to result in adverse health effects.
39
Sustained Stress Environment
Cellular adaptation to its environment so that it can survive and proliferate.A basic tenet of evolutionary biology.
In the case of exposure to a chemical stressor, the changes in a cell or tissue that allow the tissue, organ, and organism to continue to function and survive.
Karpinets and Foy: Journal of Theoretical Biology 227 (2004) 253–264Karpinets and Foy: Carcinogenesis vol.26 no.8 pp.1323--1334, 2005
40
Toxicity Testing in 21st Century: A Vision and a Strategy
Modified from NRC, 2007
Source
Fate/Transport
Exposure
Tissue Dose
Biologic Interaction
Perturbation
BiologicInputs
NormalBiologicFunction
Morbidityand
Mortality
Cell Injury
Adaptive StressResponses
Early CellularChanges
• Quantitative Dose-Response• PK / PD• Toxicity Pathway Identification• in silico models •Targeted Testing
Toxicity Pathways: Cellular response pathways that, when sufficiently perturbed, are expected to result in adverse health effects.
New Normal State of Biological Function
Potential change in susceptibility
41
ILSI Health and Environmental Sciences Institutewww.hesiglobal.org
Distinguishing Adverse from Adaptive, Non-functional and Pharmacological Changes in Toxicity Studies Subcommittee
Develop an approach for evaluating the range from benign to adverse and use it for safety assessment of chemicals/pharmaceuticals.
Develop criteria to facilitate the determination of adverse from other types of changes.
Develop an evaluation framework that integrates and prioritizes information that characterizes changes biological systems.
Draft definitions:Adverse Effect: A change in morphology, physiology, growth, development, reproduction, or life span of a cell or organism, system, or (sub)population that results in an impairment of functional capacity, an impairment of the capacity to compensate for additional stress, or an increase in susceptibility to other influences.
Adaptive Effect: In the context of toxicology, adaptability is the process whereby a cell or organism responds to a xenobiotic so that the cell or organism will survive in the new environment that contains the xenobiotic without impairment of function.
42
Adverse Outcome PathwayER-Mediated Reproductive Impairment
Chemical effects across levels of biological organization
Greater Toxicological Understanding Greater Risk RelevanceAdverse Outcome Pathway
QSAR focus area
Chemicals
ReceptorBinding
ER Binding
Liver CellProtein
Expression
Vitellogenin (egg protein
transported to ovary)
LiverAltered
proteins(Vtg)& hormones;
GonadOva-testis;Complete
ovary in male
Sex reversal;
Altered behavior;
Repro.
In vivo
MOLECULARTarget
CELLULARResponse
TISSUE/ORGAN INDIVIDUAL
Skewed Sex
Ratios;
Yr Class
POPULATION
Toxicity Pathway
In vitro Assayfocus area
43
Associating Bioactivity in vitro with Pathways and Diseases
44
Chemical Space
C2Cl3
ClClC
C2Cl3
ClClC
Cl
ClClCl
Cl
Cl
ClClCl
Cl
Cl
Cl
ClOH
OH OH
Cl
ClOH
Cl
ClClCl
Cl
Cl
ClClCl
Cl
ClC2Cl3
ClClC
C2Cl3
ClClC
Cl
ClClCl
Cl
Cl
ClClCl
Cl
Cl
Cl
ClOH
OH OH
Cl
ClOH
Cl
ClClCl
Cl
Cl
ClClCl
Cl
ClC2Cl
3
Cl C
lC
C2Cl3
Cl C
lC
C2Cl3
Cl C
lC
C2Cl3
Cl C
lC
Cl
Cl
Cl
Cl C
l
ClC
l
Cl
Cl C
l
Cl
Cl
Cl
Cl
Cl C
l
ClC
lCl
Cl C
l
Cl
Cl C
l
OH
OH
OH
Cl C
l
OH
Cl
Cl
Cl
Cl C
l
ClC
lCl
Cl C
l
Cl
OH
C2Cl3
Cl C
lC
Cl C
l
OH
Cl C
l
OH C
l
Cl
Cl
Cl C
l
ClC
lCl
Cl C
l
Cl
OH
Cl
Cl
Cl
Cl C
l
ClC
l
Cl
Cl C
l
Cl
Cl C
l
OH
Cl C
l
OH
Cl
Cl
Cl
Cl C
l
ClC
lCl
Cl C
l
Cl
OH
Cl C
l
OH
OH
OH
Cl C
l
OH C
l
Cl
Cl
Cl C
l
ClC
lCl
Cl C
l
Cl
OH
Cl
Cl
Cl
Cl C
l
ClC
l
Cl
Cl C
l
Cl
Cl C
l
OH
Cl C
l
OH
Cl
Cl
Cl
Cl C
l
ClC
l
Cl
Cl C
l
Cl
OH
Cl C
l
OHC
l Cl
OH C
l
Cl
Cl
Cl C
l
ClC
lCl
Cl C
l
Cl
OH
Cl
Cl
Cl
Cl C
l
ClC
l
Cl
Cl C
l
Cl
Cl C
l
OH
Cl C
l
OH
Cl
Cl
Cl
Cl C
l
ClC
l
Cl
Cl C
l
Cl
OH
Cl C
l
OH
Quantitative Structure Activity Relationships
Quantitative Biological Activity Response
Adverse Outcome Space
Biological Activity Space
Developmental Defects
Endocrine Disruption
Respiratory Disease
Neurologic Effects
Cancer
45
Clustering Using Inherent Properties for Cumulative Risk Evaluation
Chemistry-based Characteristics
356
21
27
100
350 429
6
Biological Responses
Use and Exposure Considerations
46
ILSI Health and Environmental Sciences Institutewww.hesiglobal.org
Emergence of Animal Alternative Needs in Environmental Risk AssessmentDevelopment of a sound technical basis for alternative tests as a means to reduce, refine, or replace standard fish toxicity test procedures.
Risk Assessment for the 21st Century: a Vision and a Plan (Risk21)
Bring applicable, accurate, and resource-appropriate approaches to the evolving field of human health risk assessment.
Center for Alternatives to Animal Testing Johns Hopkins Bloomberg School of Public Health
http://caat.jhsph.edu
Ongoing workshops in support of implementation of NAS vision.
Increa
sing
certa
inty
Exposure, Dose and Route, Mode of Action/Relevance, in
vitro assays, in vivo assays, in silico evaluation, level of
acceptance, integration of information
Exposure, Dose and Route, Mode of Action/Relevance,
in vitro assays, in vivo assays, in silico evaluation,
level of acceptance, integration of information
Exposure, Dose and Route, Mode of Action/Relevance, in vitro assays, in vivo assays, in silicoevaluation, level of acceptance, integration of information
We equate more extensive evaluation with moreanimal testing.
This is the current model, the future will be different.
It may not necessarily require more animal testing
It may mean more detailed in vitro assays, enhanced exposure assessment, greater specificity of in silico models.
47Greater certainty necessitates increased understanding, quantitative data, and greater integration at each level.
48
Modeling Toxicity From Pathways to Virtual Tissues
chemicals tissue functionpathways networks cell states
Quantitative Dose-Response
Models
Quantitative Dose-Response
Models Future
Risk assessmentsFuture
Risk assessments
Identify Key Targets and Pathways Identify Key Targets and Pathways
Moving beyond empirical models, to multi-scale computer models of complex biological systems.
49
Situational and Toxicity Pathway Based Assessments
Identify relevant adverse response in humans and wildlife
Describe Modes of Action
Identify Key Events
Develop and apply in vitro assays Tissue and cellular dose
High-throughput screens
Additional targeted testing as needed based on results
Assessment of Risk
Risk Context/Lifecycle Assessment/Exposure Context
Chemical Structure and Physical Chemical Properties/TTC Enhanced interpretation of data
50
What Is Needed To Achieve The Goal Of An Integrated Evaluation Strategy That Provides The Necessary Knowledge For Chemical Risk Assessment.
51
Toxicity Testing in 21st Century: A Vision and a Strategy
In support of a paradigm shift from the use of experimental animals and apical end points to more efficient in vitro and computational techniques.
Shift in orientation and perceptionchampions of new approach
Change in expertise and experiencetraining and staffing
Supportive policies and incentivesreward use of new technologiesuse data in assessment processescongressional implementationsupport conducting new toxicity testinguse for regulationre-examine testing programs and guidance's
Interpretation of adverse effects through perturbations of pathwaysCommunication
52
http://www.epa.gov/pesticides/science/testing-assessment.html
53
Council of Canadian AcademiesThe Council supports independent, science-based, expert assessments (studies) that inform public policy development in Canada.
The Integrated Testing of Pesticides
The Minister of Health asked the Canadian Council of Academies to assess the scientific status of integrated testing strategies in assessing and regulating the risks of pesticides to both humans and environments.
What is the scientific status of the use of integrated testing strategies in the human and environmental regulatory risk assessment of pesticides?
http://www.scienceadvice.ca/en/assessments/in-progress/pesticides.aspx
54
General Concept to Move to Toxicity Pathway-Based Assessment of Potential Risk
Identify relevant human disease or rodent adverse responseWhat are the human diseases that have a significant environmental component?What are the primary rodent responses that drive our regulatory decisions?
Describe Modes of Action for these human diseases and rodent responses
Identify Key Events that describe the modes of action
Develop assays that predict or determine the activation or enhancement of key event(s)
Establish toxicokinetics – tissue and cellular dose – that initiate key event
Develop high-throughput screens for identifying activation of key events and their dose-response
Use high-throughput screens to determine the need for targeted testing
55
NAS Activities
Toxicity Pathway-Based Risk Assessment: Preparing for Paradigm Change: A Symposium Summary (2010) Highlights from a May 2009 symposium, convened at the request the U.S. Environmental Protection Agency to stimulate discussion on the application of these approaches and data in risk assessment.
Science and Decisions: Advancing Risk Assessment (2009)The report concludes that EPA's overall concept of risk assessment, which is based on the National Research Council's 1983, Red Book, should be retained but that a number of significant improvements are needed to advance the use of risk assessment in decision making.
56
The U.S. Environmental Protection Agency’s Strategic Plan for Evaluating the Toxicity of Chemicals
www.epa.gov/spc/toxicitytesting
Process of moving from research to regulatory acceptance.
Institutional Transition
Operational transition –use new types of data and models for toxicity testing and risk assessment
Organizational transition –implement new toxicity testing paradigm hiring and training of scientists with needed scientific expertise
Outreach – educate stakeholders and improve risk communication.
EPA 100/K-09/001 March 2009
57
“One of the greatest pains to human nature is the pain of a new idea.”Walter Bagehot (1826–1877), British economist.
“To innovate is not to reform”Edmund Burke (1729–1797), Irish philosopher, statesman.